|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Services-Commercialization of Marketed Products | |||||
| Services-Research and development | |||||
| License & Collaborations-Services | |||||
| Other collaboration revenue -royalties | |||||
| Other collaboration revenue -licensing | |||||
| Third parties | |||||
| Related parties | |||||
| Total revenue | |||||
| Operating expenses | |||||
| Cost of goods and services | |||||
| Research and development expenses | |||||
| Selling expenses | |||||
| Administrative expenses | |||||
| Total operating expenses | |||||
| (Loss)/income from operations | |||||
| Gain on divestment of an equity investee | |||||
| Other income/(expense) | |||||
| Interest income | |||||
| Other income | |||||
| Interest expense | |||||
| Other expense | |||||
| Total other income/(expense) | |||||
| Income/(loss) before income taxes and equity in earnings of equity investees | |||||
| Income tax expense | |||||
| Equity in earnings of equity investees, net of tax | |||||
| Net income | |||||
| Less: Net income attributable to non-controlling interests | |||||
| Net income attributable to the Company | |||||
| Earnings per share attributable to the Company (US$ per share) | |||||
| Earnings per share attributable to the Company - basic (US$ per share) | |||||
| Earnings per share attributable to the Company - diluted (US$ per share) | |||||
| Number of shares used in per share calculation | |||||
| Number of shares used in per share calculation-basic (in shares) | |||||
| Number of shares used in per share calculation-diluted (in shares) |
Loading...